135 related articles for article (PubMed ID: 17905943)
1. Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women.
Michaud DS; Wolpin B; Giovannucci E; Liu S; Cochrane B; Manson JE; Pollak MN; Ma J; Fuchs CS
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2101-9. PubMed ID: 17905943
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of plasma C-peptide and colorectal cancer risk in men.
Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.
Bao Y; Giovannucci EL; Kraft P; Stampfer MJ; Ogino S; Ma J; Buring JE; Sesso HD; Lee IM; Gaziano JM; Rifai N; Pollak MN; Cochrane BB; Kaklamani V; Lin JH; Manson JE; Fuchs CS; Wolpin BM
J Natl Cancer Inst; 2013 Jan; 105(2):95-103. PubMed ID: 23243202
[TBL] [Abstract][Full Text] [Related]
4. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers.
Stolzenberg-Solomon RZ; Graubard BI; Chari S; Limburg P; Taylor PR; Virtamo J; Albanes D
JAMA; 2005 Dec; 294(22):2872-8. PubMed ID: 16352795
[TBL] [Abstract][Full Text] [Related]
5. Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer.
Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
Cancer Res; 2007 Aug; 67(16):7923-8. PubMed ID: 17699799
[TBL] [Abstract][Full Text] [Related]
6. Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort.
Grote VA; Kaaks R; Nieters A; Tjønneland A; Halkjær J; Overvad K; Skjelbo Nielsen MR; Boutron-Ruault MC; Clavel-Chapelon F; Racine A; Teucher B; Becker S; Pischon T; Boeing H; Trichopoulou A; Cassapa C; Stratigakou V; Palli D; Krogh V; Tumino R; Vineis P; Panico S; Rodríguez L; Duell EJ; Sánchez MJ; Dorronsoro M; Navarro C; Gurrea AB; Siersema PD; Peeters PH; Ye W; Sund M; Lindkvist B; Johansen D; Khaw KT; Wareham N; Allen NE; Travis RC; Fedirko V; Jenab M; Michaud DS; Chuang SC; Romaguera D; Bueno-de-Mesquita HB; Rohrmann S
Br J Cancer; 2012 May; 106(11):1866-74. PubMed ID: 22617158
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms.
Babic A; Bao Y; Qian ZR; Yuan C; Giovannucci EL; Aschard H; Kraft P; Amundadottir LT; Stolzenberg-Solomon R; Morales-Oyarvide V; Ng K; Stampfer MJ; Ogino S; Buring JE; Sesso HD; Gaziano JM; Rifai N; Pollak MN; Anderson ML; Cochrane BB; Luo J; Manson JE; Fuchs CS; Wolpin BM
Cancer Res; 2016 Dec; 76(24):7160-7167. PubMed ID: 27780823
[TBL] [Abstract][Full Text] [Related]
8. Postprandial Duration Influences the Association of Insulin-Related Dietary Indexes and Plasma C-peptide Concentrations in Adult Men and Women.
Tabung FK; Nimptsch K; Giovannucci EL
J Nutr; 2019 Feb; 149(2):286-294. PubMed ID: 30590589
[TBL] [Abstract][Full Text] [Related]
9. Dietary insulin load, dietary insulin index, and risk of pancreatic cancer.
Bao Y; Nimptsch K; Wolpin BM; Michaud DS; Brand-Miller JC; Willett WC; Giovannucci E; Fuchs CS
Am J Clin Nutr; 2011 Sep; 94(3):862-8. PubMed ID: 21775564
[TBL] [Abstract][Full Text] [Related]
10. Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts.
Stolzenberg-Solomon RZ; Newton CC; Silverman DT; Pollak M; Nogueira LM; Weinstein SJ; Albanes D; Männistö S; Jacobs EJ
Am J Epidemiol; 2015 Aug; 182(3):187-97. PubMed ID: 26085045
[TBL] [Abstract][Full Text] [Related]
11. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.
Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
Br J Cancer; 2007 Jul; 97(1):98-104. PubMed ID: 17533398
[TBL] [Abstract][Full Text] [Related]
12. Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?
Nogueira LM; Newton CC; Pollak M; Silverman DT; Albanes D; Männistö S; Weinstein SJ; Jacobs EJ; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):914-922. PubMed ID: 28096201
[No Abstract] [Full Text] [Related]
13. Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers.
Stolzenberg-Solomon RZ; Weinstein S; Pollak M; Tao Y; Taylor PR; Virtamo J; Albanes D
Am J Epidemiol; 2008 Nov; 168(9):1047-55. PubMed ID: 18801887
[TBL] [Abstract][Full Text] [Related]
14. Prediagnostic body mass index and pancreatic cancer survival.
Yuan C; Bao Y; Wu C; Kraft P; Ogino S; Ng K; Qian ZR; Rubinson DA; Stampfer MJ; Giovannucci EL; Wolpin BM
J Clin Oncol; 2013 Nov; 31(33):4229-34. PubMed ID: 24145341
[TBL] [Abstract][Full Text] [Related]
15. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
Lukanova A; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Arslan AA; Rinaldi S; Muti P; Lenner P; Koenig KL; Biessy C; Krogh V; Riboli E; Shore RE; Stattin P; Berrino F; Hallmans G; Toniolo P; Kaaks R
Int J Cancer; 2004 Jan; 108(2):262-8. PubMed ID: 14639613
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts.
Bao Y; Giovannucci EL; Kraft P; Qian ZR; Wu C; Ogino S; Gaziano JM; Stampfer MJ; Ma J; Buring JE; Sesso HD; Lee IM; Rifai N; Pollak MN; Jiao L; Lessin L; Cochrane BB; Manson JE; Fuchs CS; Wolpin BM
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):855-61. PubMed ID: 23462920
[TBL] [Abstract][Full Text] [Related]
17. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death.
Lin Y; Tamakoshi A; Kikuchi S; Yagyu K; Obata Y; Ishibashi T; Kawamura T; Inaba Y; Kurosawa M; Motohashi Y; Ohno Y
Int J Cancer; 2004 Jul; 110(4):584-8. PubMed ID: 15122592
[TBL] [Abstract][Full Text] [Related]
18. Increased Levels of Branched-Chain Amino Acid Associated With Increased Risk of Pancreatic Cancer in a Prospective Case-Control Study of a Large Cohort.
Katagiri R; Goto A; Nakagawa T; Nishiumi S; Kobayashi T; Hidaka A; Budhathoki S; Yamaji T; Sawada N; Shimazu T; Inoue M; Iwasaki M; Yoshida M; Tsugane S
Gastroenterology; 2018 Nov; 155(5):1474-1482.e1. PubMed ID: 30076838
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers.
Stolzenberg-Solomon RZ; Albanes D; Nieto FJ; Hartman TJ; Tangrea JA; Rautalahti M; Sehlub J; Virtamo J; Taylor PR
J Natl Cancer Inst; 1999 Mar; 91(6):535-41. PubMed ID: 10088624
[TBL] [Abstract][Full Text] [Related]
20. Predictors of fasting serum insulin and glucose and the risk of pancreatic cancer in smokers.
Meinhold CL; Berrington de Gonzalez A; Albanes D; Weinstein SJ; Taylor PR; Virtamo J; Stolzenberg-Solomon RZ
Cancer Causes Control; 2009 Jul; 20(5):681-90. PubMed ID: 19083105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
